Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Biomarker and diagnostic research for alpha-mannosidosis, infantile form has been reported in the published literature.
No clinical trials have been registered for alpha-mannosidosis, infantile form.
3 publications have been identified in PubMed for alpha-mannosidosis, infantile form. Research spans Diagnostic / Biomarker (33%), Review / Meta-Analysis (33%), and Case Report / Case Series (33%).
D'Silva A (2025). [PMID: 39948021](https://pubmed.ncbi.nlm.nih.gov/39948021/). *Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics*. [Diagnostic / Biomarker]
AlAnzi T (2024). [PMID: 38800253](https://pubmed.ncbi.nlm.nih.gov/38800253/). *Cureus*. [Case Report / Case Series]
Ługowska A (2024). [PMID: 39404425](https://pubmed.ncbi.nlm.nih.gov/39404425/). *Cells*. [Review / Meta-Analysis]
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 6:50 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
AI-curated news mentioning alpha-mannosidosis, infantile form
Updated Aug 4, 2026
A case report details the clinical presentation of alpha-mannosidosis in a 3.5-year-old girl, contributing to the understanding of this rare genetic disorder. The findings may help inform future research and clinical approaches to managing alpha-mannosidosis.